Schott Pharma
![]() | |
Company type | KGaA with Aktiengesellschaft as partner with unlimited liability |
---|---|
FWB: 1SXP | |
ISIN | DE000A3ENQ51 |
Industry | Healthcare |
Founded | August 1, 2022 |
Headquarters | Mainz, Germany |
Key people | Andreas Reisse, CEO Almuth Steinkühler, CFO |
Products | Pharmaceutical drug containment and delivery systems |
Revenue | €899 million (2022/2023)[1] |
Owner | Schott AG |
Number of employees | 4,646 (as of September 30, 2023)[1] |
Divisions |
|
Website | schott-pharma |
Schott Pharma (stylized as SCHOTT Pharma) is a provider of drug containment solutions and delivery systems for injectable drugs.[2][3] Headquartered in Mainz, Germany,[4][5] the company operates in 14 countries.[6]
History
[edit]![](http://upload.wikimedia.org/wikipedia/commons/thumb/2/2c/Abf%C3%BCllautomat_1932_SCHOTT.jpg/220px-Abf%C3%BCllautomat_1932_SCHOTT.jpg)
![](http://upload.wikimedia.org/wikipedia/commons/thumb/4/4a/Druckschrift_Fiolenk%C3%B6rper_1923_SCHOTT.jpg/220px-Druckschrift_Fiolenk%C3%B6rper_1923_SCHOTT.jpg)
In 1887, Otto Schott developed borosilicate glass, a form of glassware used to reagent bottles and flasks. From 1911, Schott manufactured borosilicate glass tubing for the production of pharmaceutical ampoules and vials.[7]
Schott Pharma was established as a standalone company in 2022 under the name Schott Pharma AG & Co. KGaA[8][5] through an equity carve-out (or spin-off) from Schott AG, a manufacturer of specialty glass and glass-ceramics.[9][10]
In the same year, the company announced their plans to present an IPO, but this was reportedly postponed to 2023 due to the Ukraine war.[4] In September 2023, Schott Pharma went public on the Frankfurt Stock Exchange. The IPO was initially priced at 27€ per share,[11][12] and a potential valuation of up to 4.1 billion euros,[13] but increased the share price to 30€ the following day.[14] The IPO was the largest of the year in Germany.[15][16] In December 2023, Schott Pharma was included in the SDAX.[17]
Production & Manufacturing
[edit]![]() | This section needs expansion. You can help by adding to it. (June 2024) |
The company is headquartered in Mainz and operates in 16 locations across 14 countries.[18]
Europe
[edit]- Müllhein, Germany (Müllheim Production and Technology Centre)[19][20]
- Hungary[21][22]
- Switzerland[5]
- Serbia[22]
North America
[edit]South America
[edit]Asia
[edit]- China[21]
Products
[edit]Schott Pharma develops and manufactures drug containment solutions and delivery systems for injectable drugs, which it supplies to companies in the biotechnology and pharmaceutical industries.[23]
Its business is divided into two divisions:
- Drug Containment Solutions: pharmaceutical vials, cartridges, and glass ampoules[24]
- Drug Delivery Systems: prefillable glass syringes and syringes made from Cyclic olefin copolymers (COC), suitable for deep-cold medications.[25]
Governance
[edit]Schott Pharma is a subsidiary of SCHOTT AG, who has controlling shares of 77%(as of 2023: 77%).[16][14] SCHOTT AG is owned by the Carl Zeiss Foundation.[21]
Schott Pharma was listed on the Frankfurt Stock Exchange's SDAX in 2023.
![]() | This section needs expansion. You can help by adding to it. (June 2024) |
Parent Company Board of Directors
[edit]- Frank Heinricht (CEO of Schott AG) [19]
- Almuth Steinkühler (Chief Financial Officer of Schott AG)[26]
Independent Supervisory Board
[edit]In 2023 SCHOTT AG appointed a Supervisory Board for the subsidiary Schott Parma AG as follows:[27][28]
- Peter Goldschmidt, (Chairman)
- Dr. Wolfgang Wienand (Chairman of the Executive Board of Siegfried Holding AG)
- Eva Kienle (CFO of KWS Saat SE & Co. KGaA)
- Ann-Kristin Erkens (Corporate Senior Vice President, Financial and Business Controlling at Henkel Adhesive Technologies)
- Christine Wening (employee stakeholder)
- Mario Just (employee stakeholder)
Financial Results
[edit]![]() | This section needs expansion. You can help by adding to it. (June 2024) |
2022/23 | 2023/24 | ||
---|---|---|---|
Turnover | |||
Net Profit | |||
References
[edit]- ^ a b SCHOTT Pharma Annual Report 2022/2023 (accessed February 08, 2024)
- ^ Kansteiner, Fraiser (2023-12-23). "Glass specialist Schott Pharma touts 2023 sales growth, Serbia expansion and hiring plans". Fierce Pharma. Retrieved 2024-04-08.
- ^ "EQS-News: SCHOTT Pharma bestätigt Prognose für das Geschäftsjahr 2024 anlässlich seiner Q2-Ergebnisse; Geschäftsjahr 2025 durch geringeres Wachstum bei Spritzen beeinflusst" [EQS-News: SCHOTT Pharma confirms forecast for the 2024 financial year on the occasion of its Q2 results; financial year 2025 influenced by lower growth in syringes]. 4Investors.de (in German). 2024-05-14. Retrieved 2024-06-24.
- ^ a b Ibrahim, Samir (2023-09-28). "Schott Pharma startet erfolgreich an der Frankfurter Börse". tagesschau.de (in German). Retrieved 2024-06-24.
- ^ a b c Nünchert, Ike (2022-08-03). "SCHOTT Pharma: Carve-Out für ein mögliches IPO" [SCHOTT Pharma: Carve-Out for a possible IPO]. Going Public. Retrieved 2024-06-24.
- ^ "Größter Börsengang in 2023: So hat sich die SCHOTT Pharma-Aktie seit ihrem IPO entwickelt - und so könnte es in 2024 nun weitergehen". finanzen.net. 2024-01-24. Retrieved 2024-02-28.
- ^ "Impfstoff-Ampullen – Rohrglas für Lebensretter - VBG Spezial". glaskeramik.org. VBG. 2021-07-04. Retrieved 2024-02-28.
- ^ Dunleavy, Kevin (2023-09-06). "After one year as standalone business, glassmaker Schott Pharma sets course for IPO". Fierce Pharma. Retrieved 2024-06-24.
- ^ Kansteiner, Fraiser (2022-01-08). "Glass maker Schott's pharma business sets out on its own. Will an IPO follow?". Fierce Pharma. Retrieved 2024-02-28.
- ^ Landsteiner, Fraiser (2022-08-01). "Glass maker Schott's pharma business sets out on its own. Will an IPO follow?". Fierce Pharma. Retrieved 2024-06-24.
- ^ Gopinath, Swetha (2023-09-28). "Germany's Schott Raises €813 Million in IPO of Medical-Glass Arm". www.bloomberg.com. Retrieved 2024-06-24.
- ^ gsp (2023-09-29). "Schott Pharma geht mit Freshfields an die Frankfurter Börse" [Schott Pharma goes to the Frankfurt Stock Exchange with Freshfields]. Extrajournal.Net (in German). Retrieved 2024-06-24.
- ^ "Schott Pharma prices IPO at 27 euros per share". Reuters. 2023-09-27. Retrieved 2024-06-24.
- ^ a b "SCHOTT Pharma feiert erfolgreiches Börsendebüt: Erstkurs über Ausgabepreis" [SCHOTT Pharma celebrates successful stock market debut: First price on issue price]. Finanzen Net (in German). 2023-09-28. Retrieved 2024-06-24.
- ^ Farr, Emma-Victoria; Mayo Cerqueiro, Pablo (2023-09-28). "Schott Pharma shares jump 16% in Frankfurt trading debut". reuters.com. Reuters. Retrieved 2024-02-28.
- ^ a b "Schott Pharma startet erfolgreich an der Börse". tagesschau.de. 2023-09-28. Retrieved 2024-02-28.
- ^ Ingerl, Christian (2023-12-13). "Profitabler Small Cap: Zulieferer Schott Pharma bald im SDax". Capital. Retrieved 2024-02-28.
- ^ "Größter Börsengang in 2023: So hat sich die SCHOTT Pharma-Aktie seit ihrem IPO entwickelt - und so könnte es in 2024 nun weitergehen". finanzen.net. 2024-01-24. Retrieved 2024-02-28.
- ^ a b Zeitung, Badische (2022-12-02). "SCHOTT Pharma: Ein globales Kompetenzzentrum in Müllheim". Badische Zeitung (in German). Retrieved 2024-06-24.
- ^ Schlegel, Marion (2023-12-19). "SDAX-Neuling Schott Pharma gibt ordentlich Gas: Zahlen kommen gut an". www.deraktionaer.de (in German). Retrieved 2024-06-24.
- ^ a b c "SCHOTT Pharma baut Produktion in China und Ungarn aus – ZWP online – das Nachrichtenportal für die Dentalbranche". www.zwp-online.info (in German). 2022-09-22. Retrieved 2024-06-24.
- ^ a b "SCHOTT: solides Ergebnis trotz konjunktureller Herausforderungen – ZWP online – das Nachrichtenportal für die Dentalbranche" [SCHOTT: solid result despite economic challenges]. www.zwp-online.info (in German). 2024-02-12. Retrieved 2024-06-24.
- ^ SCHOTT Pharma Annual Report 2022/2023, SCHOTT Pharma, p. 14, retrieved 2024-02-28
- ^ Kaiser, Lea (2023-10-24). "Next generation pharma glass: SCHOTT AG launches FIOLAX® Pro Glass tubing". BusinessWire. Retrieved 2024-06-24.
- ^ "Schott Pharma rolls out pre-filled polymer syringes for deep-cold medication". NS Medical Devices. 2023-05-18. Retrieved 2024-02-28.
- ^ Kolf, Ingo (2024-05-15). "Kurs bricht ein: Schott Pharma: Trübe Aussichten führen zu drastischem Kurseinbruch". FinanzNachrichten.de (in German). Retrieved 2024-06-24.
- ^ Mills, Jess (2023-05-02). "Schott appoints Supervisory Board of Schott Pharma". Glass International. Retrieved 2024-06-24.
- ^ "SCHOTT bestellt Aufsichtsrat der SCHOTT Pharma AG" [SCHOTT appoints Supervisory Board of SCHOTT Pharma AG]. ZWP-online. 2023-05-02. Retrieved 2024-06-24.